Stories — June 2020
- My New Normal: 9 Questions With CBT Principal Haril Pandya
- Starbucks To Reinvent Some Locations Post-Pandemic, About 400 Others To Close
- Is The Golden Age Of Central Business Districts Over? Experts Say Maybe.
- Long-Term Eviction Ban Proposed By California Lawmakers
- Peninsula Office Project Gets $33.8M Construction Loan
- Developer Of Ritzy Manhattan Condos Suing Bank For Backing Out Of Construction Loan
- In A Market Shaped By The Pandemic, Patient Investors Will Be The Big Winners
- Proptech Startup Snags $10M As Demand For Office Tech Grows
- Construction Industry Sees Supply Chain Shift Away From China, Spooked Capital Markets
- Mall Of America Owner Staring Down Billions In Debt
- Long-Dreamed Train To Miami Beach Could Be A Monorail
- ‘People Are Just Exhausted’: What Happens When A Business Decides It Can't Go On
- Secret Talks Due As £1.5B Lendlease Birmingham Smithfield Deal Approaches
- Architecture Firm SLAM Buys 5 CBRE I Heery Practices
- Expect Another Wave Of Retail Bankruptcies By Year's End
- Supply Chain Breaks Put New Spotlight On Central Valley's Potential
- Warehouse Rents Rising As Post-Pandemic Reality Bites
- Hines, MetLife Start Luxury Project In Ambitious Bay Area City
- Jeff Blau: Related Will Be Coming Back To Office 'In Full Force'
- The Hollowing Out Of The Prime Birmingham Office District
- One Of Manhattan’s Priciest Hotels Is In Default. A Foreclosure Sale Is Scheduled For This Month.
- JV Will Invest $250M In SoCal Multifamily
- Morgan Stanley Starts Review Of 800K SF London Offices
- E-Tailers Bolstering Top Shopping Districts And May Soon Make The Leap To The Magnificent Mile
- NYC's Office Buildings Are Readying To Reopen, But Most Workers Aren't Ready To Come Back
- Simon Nixes Its Acquisition Of Taubman
- ‘Hub-And-Spoke’ Office Model Gains Traction With CRE Investors
- Miami After 90 Days Of Coronavirus: 'The Distress Is Definitely Coming'
- Banks Won’t Fail This Time, But A Credit Crunch And Debt Distress Still Loom For Real Estate
- Philadelphia Life Sciences Sector Chasing Rivals In Boston